CRISPR Editing Appears Effective in Three Patients with Rare Diseases
source: pixabay.com

CRISPR Editing Appears Effective in Three Patients with Rare Diseases

According to a story from interestingengineering.com, the capabilities of CRIPSR gene editing technology have been creating a buzz in the medical field for years now, with many seeing the technology…

Continue Reading CRISPR Editing Appears Effective in Three Patients with Rare Diseases

New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a

A study conducted by researchers from Aix-Marseille University in France has revealed a new way to track disease progression of Charcot-Marie-Tooth disease type 1a (CMT1a)- changes to the nerves within the thigh.…

Continue Reading New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a
$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
QuinceMedia / Pixabay

$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders

Every day, the world becomes increasingly technological. With this comes advances in many realms, from healthcare to education. Recently, says Parkinson's News, medical technology company Manus Neurodynamica received £750,000 (approx. $950,000)…

Continue Reading $950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
Visually Impaired and Academically Driven? Canada has a New Scholarship for You
source: pixabay.com

Visually Impaired and Academically Driven? Canada has a New Scholarship for You

As reported in Globe News Wire, amidst a difficult time for rare disease patients as the medical world’s refocuses on the coronavirus, a new scholarship has been announced that could…

Continue Reading Visually Impaired and Academically Driven? Canada has a New Scholarship for You
New Project on Manganese Exposure Could Shape Parkinson’s Disease Research
Photo by Glenn Hansen on Unsplash

New Project on Manganese Exposure Could Shape Parkinson’s Disease Research

What better way to study Parkinson's disease than...to not study it? Well, according to Parkinson's News Today, researchers are hoping to learn more about the disorder by doing just that.…

Continue Reading New Project on Manganese Exposure Could Shape Parkinson’s Disease Research

Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias

Celldex has just released positive results from a Phase 1 trial of an investigative therapy which could benefit patients living with chronic urticarias. This disease can result in decreased energy,…

Continue Reading Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias
Scientists Discover a Connection Between the Genome’s Dark Matter and Autoimmune Diseases
source: pixabay.com

Scientists Discover a Connection Between the Genome’s Dark Matter and Autoimmune Diseases

  Babraham and Wellcome Sanger Institutes partnered in a major research project and discovered a connection between the genome’s non-protein coding ‘dark matter’ region and autoimmune or allergic diseases. A…

Continue Reading Scientists Discover a Connection Between the Genome’s Dark Matter and Autoimmune Diseases

Scientists Are Using a New Approach to Slow Parkinson’s Progression Through Two Compounds

A study led by Yoon Ho Sup, a Professor at NTU Singapore, and Kwang-Soo Kim, a professor at Harvard University, has uncovered two compounds with the ability to increase the…

Continue Reading Scientists Are Using a New Approach to Slow Parkinson’s Progression Through Two Compounds

CASI Pharmaceuticals Files CTA (IND) for Novel Multiple Myeloma Treatment

  According to a recent press release, biopharmaceutical company CASI Pharmaceuticals filed a Clinical Trial Application (CTA) (IND) in the United Kingdom. CASI Pharmaceuticals is hoping to test the safety…

Continue Reading CASI Pharmaceuticals Files CTA (IND) for Novel Multiple Myeloma Treatment
Close Menu